About
ReGEN Biomedical develops automated platforms to produce robust, reproducible human micro-tissues for use in drug screening, toxicity testing, and ex vivo disease models, and works on assembling these micro-tissues into larger macro-tissues for regenerative medicine applications.
Explore ReGEN Biomedical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.